Mengis Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$962K Sell
13,394
-600
-4% -$46.2K 0.17% 117
2025
Q4
$1.11M Sell
13,994
-3,361
-19% -$265K 0.2% 104
2025
Q3
$1.31M Sell
17,355
-1,750
-9% -$120K 0.26% 98
2025
Q2
$1.32M Sell
19,105
-4,225
-18% -$277K 0.28% 93
2025
Q1
$1.58M Sell
23,330
-700
-3% -$41.9K 0.33% 77
2024
Q4
$1.08M Sell
24,030
-22,359
-48% -$1.25M 0.22% 97
2024
Q3
$2.92M Sell
46,389
-3,347
-7% -$195K 0.57% 48
2024
Q2
$2.94M Sell
49,736
-4,273
-8% -$267K 0.6% 48
2024
Q1
$4.31M Sell
54,009
-4,593
-8% -$351K 0.66% 38
2023
Q4
$4.63M Sell
58,602
-822
-1% -$58.5K 0.87% 27
2023
Q3
$4.15M Sell
59,424
-573
-1% -$40.6K 0.86% 25
2023
Q2
$4.15M Sell
59,997
-2,263
-4% -$161K 0.83% 27
2023
Q1
$4.63M Sell
62,260
-1,523
-2% -$128K 0.97% 24
2022
Q4
$5.94M Sell
63,783
-54
-0.1% -$5.21K 1.3% 19
2022
Q3
$6.09M Sell
63,837
-4,234
-6% -$419K 1.44% 17
2022
Q2
$6.31M Sell
68,071
-1,795
-3% -$175K 1.39% 18
2022
Q1
$7.07M Buy
69,866
+102
+0.1% +$10.7K 1.36% 18
2021
Q4
$7.2M Buy
69,764
+551
+0.8% +$50.9K 1.35% 17
2021
Q3
$5.87M Buy
69,213
+301
+0.4% +$25.2K 1.23% 20
2021
Q2
$5.75M Sell
68,912
-249
-0.4% -$20.4K 1.19% 21
2021
Q1
$5.2M Sell
69,161
-168
-0.2% -$12.2K 1.15% 22
2020
Q4
$4.74M Buy
69,329
+8,877
+15% +$577K 1.15% 21
2020
Q3
$3.53M Buy
60,452
+4,233
+8% +$263K 0.97% 27
2020
Q2
$3.65M Buy
56,219
+2,505
+5% +$158K 1.08% 23
2020
Q1
$3.19M Buy
53,714
+7,250
+16% +$484K 1.09% 23
2019
Q4
$3.45M Buy
46,464
+3,220
+7% +$226K 0.95% 29
2019
Q3
$2.73M Buy
43,244
+14,709
+52% +$872K 0.81% 36
2019
Q2
$1.55M Buy
28,535
+10,805
+61% +$582K 0.48% 66
2019
Q1
$956K Buy
17,730
+4,200
+31% +$259K 0.53% 62
2018
Q4
$886K Hold
13,530
0.56% 58
2018
Q3
$1.06M Buy
13,530
+1,650
+14% +$118K 0.59% 57
2018
Q2
$764K Buy
11,880
+600
+5% +$39.5K 0.45% 67
2018
Q1
$701K Hold
11,280
0.42% 69
2017
Q4
$817K Sell
11,280
-85
-0.7% -$6.18K 0.49% 59
2017
Q3
$924K Sell
11,365
-50
-0.4% -$3.96K 0.62% 51
2017
Q2
$918K Buy
11,415
+75
+0.7% +$5.92K 0.65% 48
2017
Q1
$890K Buy
11,340
+6,540
+136% +$522K 0.65% 48
2016
Q4
$378K Buy
+4,800
New +$388K 0.3% 81

Other funds holding CVS

Mengis Capital Management's CVS Position: Q1 2026 in Review

Mengis Capital Management reduced its CVS Health (CVS) stake by 4.3% in Q1 2026, selling an estimated $46.2K and leaving 13,394 shares worth $962K. The position accounts for 0.17% of the portfolio, ranked #117.

Mengis Capital Management first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $7.2M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Mengis Capital Management held 13,394 shares of CVS Health worth $962K as of Q1 2026.
  • Mengis Capital Management sold 600 CVS Health shares in Q1 2026, an estimated $46.2K.
  • CVS Health made up 0.17% of Mengis Capital Management's portfolio in Q1 2026, its #117 holding.
  • Mengis Capital Management first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
  • Mengis Capital Management's CVS Health position peaked at $7.2M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.